Assyro AI
FDA Purple Book · Reference family

Coagulation Factor X (Human) (Coagadex)

Coagulation Factor X (Human) is an FDA-licensed reference biologic from Bio Products Laboratory Limited. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.

0

Biosimilars

0

Interchangeables

0

Listed patents

2015

Reference approved

Reference product

351(a)BLA 125506

Coagadex Coagulation Factor X (Human)

Bio Products Laboratory Limited

Approved
Oct 20, 2015
Marketing
Rx
Center
CBER
Patents
None listed

Exclusivity & patent cliffs

Approval, exclusivity, and published-patent expiration dates for Coagulation Factor X (Human), in chronological order.

  1. Reference approval

    Approval date of the reference Coagulation Factor X (Human) product.

    10 yr 9 mo ago

  2. Orphan exclusivity ends

    7-year orphan-drug exclusivity window.

    in 3 yr 11 mo

Frequently asked questions

Are there biosimilars approved for Coagulation Factor X (Human) (Coagadex)?

No 351(k) biosimilars or interchangeable biosimilars referencing Coagulation Factor X (Human) are listed in the FDA Purple Book yet.

Explore the full FDA Purple Book

Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.

Open the Purple Book tool